information
Whoever comes in this website may find a hint
Phage therapy is influenced by:
Phage therapy is influenced by:
Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view
Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view
From Wikipedia
If the target host* of a phage therapy treatment is not an animal the term "biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".
"In silico"
From:"Genomics,Proteomics and Clinical Bacteriology", N.Woodford and Alan P.Johnson
Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.
Wednesday, 2 July 2014
Delivered routes used in phage therapy
Parental delivery of bacteriophages
-IM, intramuscular
-SC, subcutaneous
-IP, intraperitoneal(the best)
Oral delivery of bacteriophages
Local delivery of bacteriophages
Topical administration of bacteriophages
Otic administration of bacteriophages
Dental administration of bacteriophages
Inhalation of bacteriophages
Tuesday, 1 July 2014
3°- Is Cystic fibrosis disease a potential target for Biocontrol?
Tuesday, 20 July 2010
In a patient whit cystic fibrosis disease the main obstacle, as a consequence of a biocontrol (phage therapy) treatment could be a possible dangerous developping reaction both to local level and/or to general level, caused by a massive release of endotoxin from lysed bacteria.

At moment we do not have data about this possible negative side effect by phage administration but in the Historical document (AD NUMBER AD837021)* is described a real application which does not provide any information about this question.
*"Aerosol treatment was administered every day. The duration of the individual sessions usually lasted 10-15 minutes. The average number of inhalations administered amounted to 11, the smallest number was 3 (this involved a subchronical tracheobronchitis), and the largest number was 40".

Herxheimer reaction
From:
Bacterial Endotoxin in Human Disease
If we want to avoid this side effect we must study a specific administration cycle for a patient with cystic fibrosis in terms of:
- Phage Dose
- Treatment Lenght
- Treatment Number
- Endotoxin Monitoring
My idea is to prepare a specific Phage cocktail and to add to this cocktail a proporzionate quantity of Polymyxin B* ( in this case the evaluations regarding the potential damages for toxicity by use of Polymyxin B must be made before all ).
Main Drug= Phages
LPS neutralizing= Polymyxin B

Polymyxin B is present for neutralizing the LPS that is released from phage- lysed bacteria.
Finally, after test, to use this synergetic composition by:
-aerosol therapy (Phages and Polymyxin B together or alternatively to use two close and separeted aerosol administrations, Phages before and Polymyxin B after )
or
-Phages by aereosol and Polymyxin B by hemoperfusion .
2°- Is Cystic fibrosis disease a potential target for Biocontrol?
old post:
Sunday, 18 July 2010
Microbial ecology of the cystic fibrosis lung*
Haemophilus influenzae
Staphylococcus aureus
Pseudomonas aeruginosa
Burkholderia cepacia complex (BCC)

A, Aspergillus spp.; AV, adenovirus;AX, A. xylosoxidans; BP, bacteriophage; C, Candida spp.; Ent, enterobacteria; IPV, influenza and/or parainfluenza virus; K, Klebsiella spp.;
M, mycoplasma; MA, Mycobacterium abscessus; N, Neisseria spp.; OF, oropharyngeal flora; RSV,respiratory syncytial virus; SM, S. maltophilia.
From Wikipedia: Metagenomics
"Metagenomics is the study of metagenomes, genetic material recovered directly from environmental samples. The broad field may also be referred to as environmental genomics, ecogenomics or community genomics. Traditional microbiology and microbial genome sequencing rely upon cultivated clonal cultures. This relatively new field of genetic
research enables studies of organisms that are not easily cultured in a
laboratory as well as studies of organisms in their natural
environment.[1]Early environmental gene sequencing cloned specific genes (often the 16S rRNA gene) to produce a profile of diversity in a natural sample. Such work revealed that the vast majority of microbial biodiversity had been missed by cultivation-based methods.[2] Recent studies use "shotgun" Sanger sequencing or massively parallel pyrosequencing to get (mostly) unbiased samples of all genes from all members of sampled communities.[3]"
From:
Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals*
"We obtained sequences from sputum DNA viral communities in 5 individuals with cystic fibrosis (CF) and 5 individuals without the disease. Overall, diversity of viruses in the airways was low, with an average richness of 175 distinct viral genotypes. The majority of viral diversity was uncharacterized.CF phage communities were highly similar to each other, whereas Non-CF individuals had more distinct phage communities, which may reflect organisms in inhaled air.
CF eukaryotic viral communities were dominated by a few viruses, including human herpesviruses and retroviruses.
From:
Deciphering the role of phage in the cystic fibrosis airway*
"There was a striking difference in metabolic functions encoded by phage in CF versus Non-CF individuals.Regardless of which viral taxa were present,CF-associated phage shared a common core metabolism that reflected the disease state and aberrant airway physiology".
From:
Mathematical Modeling of Cystic Fibrosis Ecology*
"A complete mathematical model of CF would need equations that follow the concentrations of all different kinds of bacterial and phage species in each compartment"
See QUORUM SENSING*
Comment*
For phages and bacteria the human body is only a component of their world in which at all times and on all occasions they are fighting.
1°-Is Cystic fibrosis disease a potential target for Biocontrol?
old post:
Sunday, 18 July 2010
Historical document
(phage administration in humans)
AD NUMBER
AD837021

Diriphagen
"We used the preparation (Diriphagen : Dr.Heinz Haury Chemical Plant, Munich) because we believed that this preparation met the requirements we just set up. According to Information received, this preparation contains 180-200 different phage strains and thus has a broad spectrum of effectiveness"
Today........
From:
Toward Modern Inhalational Bacteriophage Therapy:Nebulization of Bacteriophages of Burkholderia cepacia Complex
"The results suggest that BCC bacteriophages can be nebulized successfully within a reasonable delivery time and predicted titers in the lung indicate that this method may hold potential for treatment of bacterial lung infections common among cystic fibrosis patients"
Subscribe to:
Posts (Atom)